| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Formononetin | Alzheimer's Disease | 4 | PM | 35304289 | 📋 | Formononetin attenuates Aβ25-35-induced adhesion molecules in HBMECs via Nrf2 activation |
| Formononetin | Alzheimer's Disease | 3 | PM | 31175839 | 📋 | Pharmacological Targets and the Biological Mechanisms of Formononetin for Alzheimer's Disease: A Network Analysis |
| Formononetin | Alzheimer's Disease | 2 | PM | 29191087 | 📋 | Neuroprotective effect of formononetin in ameliorating learning and memory impairment in mouse model of Alzheimer's disease |
| Formononetin | Alzheimer's Disease | 1 | PM | 28034780 | 📋 | Formononetin attenuates Aβ25-35-induced cytotoxicity in HT22 cells via PI3K/Akt signaling and non-amyloidogenic cleavage of APP |
| Formononetin | Cerebral Ischemia-Reperfusion | 3 | PM | 38452845 | 📋 | Formononetin alleviates cerebral ischemia-reperfusion injury in rats by targeting the PARP-1/PARG/Iduna signaling pathway |
| Formononetin | Cerebral Ischemia-Reperfusion | 2 | PM | 35339827 | 📋 | Formononetin protects against inflammation associated with cerebral ischemia-reperfusion injury in rats by targeting the JAK2/STAT3 signaling pathway |
| Formononetin | Cerebral Ischemia-Reperfusion | 1 | PM | 24996490 | 📋 | Formononetin mediates neuroprotection against cerebral ischemia/reperfusion in rats via downregulation of the Bax/Bcl-2 ratio and upregulation PI3K/Akt signaling pathway |
| Formononetin | Cognitive Disorders | 2 | PM | 37403720 | 📋 | [Formononetin improves cognitive behavior in aging rats with chronic unpredictable mild in hippocampal tissue stress by blocking the NF-κB pathway and inhibiting the release of inflammatory factors] |
| Formononetin | Cognitive Disorders | 1 | PM | 31389320 | 📋 | Formononetin Ameliorates Cognitive Disorder via PGC-1α Pathway in Neuroinflammation Conditions in High-Fat Diet-Induced Mice |
| Formononetin | Depression | 2 | PM | 36610138 | 📋 | Formononetin improves cardiac function and depressive behaviours in myocardial infarction with depression by targeting GSK-3β to regulate macrophage/microglial polarization |
| Formononetin | Depression | 1 | PM | 35218705 | 📋 | The antidepressant-like effect of formononetin on chronic corticosterone-treated mice |
| Formononetin | Diabetic Encephalopathy | 1 | PM | 30119194 | 📋 | The protective effect of formononetin on cognitive impairment in streptozotocin (STZ)-induced diabetic mice |
| Formononetin | Glioma | 3 | PM | 36076540 | 📋 | The mechanism of formononetin/calycosin compound optimizing the effects of temozolomide on C6 malignant glioma based on metabolomics and network pharmacology |
| Formononetin | Glioma | 2 | PM | 31005632 | 📋 | In vitro and in vivo Study on Glioma Treatment Enhancement by Combining Temozolomide with Calycosin and Formononetin |
| Formononetin | Glioma | 1 | PM | 26261519 | 📋 | Formononetin sensitizes glioma cells to doxorubicin through preventing EMT via inhibition of histone deacetylase 5 |
| Formononetin | Ischemic Stroke | 1 | PM | 32081422 | 📋 | Formononetin recovered injured nerve functions by enhancing synaptic plasticity in ischemic stroke rats |
| Formononetin | Traumatic Brain Injury | 3 | PM | 29966980 | 📋 | Neuroprotective effect of formononetin against TBI in rats via suppressing inflammatory reaction in cortical neurons |
| Formononetin | Traumatic Brain Injury | 2 | PM | 29312517 | 📋 | Increased miR-155 and heme oxygenase-1 expression is involved in the protective effects of formononetin in traumatic brain injury in rats |
| Formononetin | Traumatic Brain Injury | 1 | PM | 24411660 | 📋 | Formononetin protects TBI rats against neurological lesions and the underlying mechanism |
